First Few Cases of Intracranial Schwannoma treated with LINAC-based Stereotactic Radiosurgery in Bangladesh

Authors

  • Narendra Kumar Professor & Head, Department of Radiation Oncology, Cancer Care Centre, Evercare Hospital, Dhaka, Bangladesh
  • Taohida Yasmin Registrar, Department of Radiation Oncology, Cancer Care Centre, Evercare Hospital, Dhaka, Bangladesh
  • Murugan Appasamy Chief Medical Physicist, Department of Radiation Oncology, Cancer Care Centre, Evercare Hospital, Dhaka, Bangladesh
  • Sania Ahsan Senior Consultant, Department of Radiodiagnosis, Evercare Hospital Dhaka, Bangladesh
  • KM Masud Rana Medical Physicist, Department of Radiation Oncology, Cancer Care Centre, Evercare Hospital, Dhaka, Bangladesh
  • Sandip Kumar Das Senior Consultant, Department of Neurology, Evercare Hospital Dhaka, Bangladesh
  • R Arun Kumar Chief Radiation Technologist, Department of Radiation Oncology, Cancer Care Centre, Evercare Hospital, Dhaka, Bangladesh
  • Zillur Rahman Senior Consultant, Department of Neurosurgery, Evercare Hospital Dhaka, Bangladesh
  • Amitabha Chanda Senior Consultant, Department of Neurosurgery, Evercare Hospital Dhaka, Bangladesh
  • Md Shafiul Alam Associate Professor, Department of Gamma Knife, National Institute of Neurosciences & Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.3329/jninb.v7i2.58118

Keywords:

LINAC; Stereotactic Radiosurgery; trigeminal schwannoma; vestibular schwannoma; complications

Abstract

Stereotactic Radiosurgery has been widely utilized for the treatment of intracranial lesions, and this paper presents our experience in treating schwannomas in Bangladesh. This case series was described to present our institutional experience and procedural technique adapted for treating intracranial schwannomas using stereotactic Radiosurgery (SRS) by Linear accelerators. This case series since starting our radiosurgery program in March 2019, we have treated three patients of intracranial schwannoma. Two patients had vestibular schwannoma, and one had Trigeminal Schwannoma. All three patients first underwent surgical intervention and on recurrence/progression treated with stereotactic Radiosurgery. Tumor volume ranged from 4.47 to 10.22 cm3. The dose prescription ranges from 13 to 14Gy in one or two fractions, which was subject to tumor volume, its proximity to a critical structure, existing neurologic deficit, and optimal balance between prescribed dose and predicted complications. All three procedure was free of any immediate adverse event. LINAC based Stereotactic Radiosurgery was found to be a safe and effective option for the treatment of schwannomas. All three patients have a very good clinical outcome, and one patient who has more than one-year post-SRS revealed a significant regression in the size of the tumor.

Journal of National Institute of Neurosciences Bangladesh, July 2021, Vol. 7, No. 2, pp. 181-189

Downloads

Download data is not yet available.
Abstract
160
PDF
119

Downloads

Published

2022-02-06

How to Cite

Kumar, N., Yasmin, T., Appasamy, M. ., Ahsan, S. ., Rana, K. M. ., Das, S. K. ., Kumar, R. A. ., Rahman, Z., Chanda, A., & Alam, M. S. . (2022). First Few Cases of Intracranial Schwannoma treated with LINAC-based Stereotactic Radiosurgery in Bangladesh. Journal of National Institute of Neurosciences Bangladesh, 7(2), 181–189. https://doi.org/10.3329/jninb.v7i2.58118

Issue

Vol. 7 No. 2 (2021)

Section

Case Series

License

Copyright (c) 2022 Narendra Kumar, Taohida Yasmin, Murugan Appasamy, Sania Ahsan, KM Masud Rana, Sandip Kumar Das, R Arun Kumar, Zillur Rahman, Amitabha Chanda, Md Shafiul Alam

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright on any research article in the Journal of National Institute of Neurosciences Bangladesh is retained by the author(s).

The authors grant the National Institute of Neurosciences Bangladesh a license to publish the article and identify itself as the original publisher.

Articles in the Journal of National Institute of Neurosciences Bangladesh are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)

This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.